Sernova is a Canadian clinical-stage biotechnology company focused on cell therapy platforms for chronic diseases, including type 1 diabetes. Its work includes implantable cell containment systems and related therapeutic technologies.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!